Is Summit's Ridinilazole a Threat to Acurx's Ibezapolstat in the C.difficile Space?
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/10/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, compares the two drugs as potential treatments for C. difficile. More >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks
Source: Matt Badiali for Streetwise Reports  (8/10/20)
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. More >

Pharmaceutical Firm Doses First Patient in Phase 2 IPF and Chronic Cough Trial
Source: Streetwise Reports  (8/8/20)
Algernon Pharmaceuticals reported that the first patient has been dosed in the Phase 2 human study of Ifenprodil for treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Biopharma Preparing to Initiate Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/7/20)
Revive Therapeutics is now "finalizing agreements and aligning resources to initiate the Phase 3 clinical trial in September." More >

Denali Shares Rise 37% on Advancement of DNL151 into Late Stage Parkinson's Trials
Source: Streetwise Reports  (8/6/20)
Shares of Denali Therapeutics reached a new 52-week high after the company reported plans to advance DNL151 in two separate late stage Parkinson's disease clinical studies with its partner Biogen. More >

US Immunology Firm Lands Government Contract, Raises Cash
Source: Streetwise Reports  (8/5/20)
These two CytoSorbents events are discussed in a Dawson James report. More >

Tech Firm Explains Key Feature of its Contact Tracing Solution
Source: Streetwise Reports  (8/5/20)
Loop Insights' technology lacks the adoption challenges that app-based solutions face. More >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue
Source: Streetwise Reports  (8/5/20)
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. More >

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients
Source: Streetwise Reports  (8/4/20)
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. More >

Biopharma Gets FDA Approval for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/4/20)
Revive Therapeutics' trial will test Bucillamine in patients with mild to moderate COVID-19. More >

Ten Good Reasons to Invest Now Pre-Market in Acurx Pharmaceuticals
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/3/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, provides his investment thesis for a company that is promulgating the first new class of antibiotics in 30 years. More >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'
Source: Streetwise Reports  (7/29/20)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. More >

Digital Health Firm Signs Deal to Acquire Vancouver Medical Clinic Serving 60,000 Patients
Source: Streetwise Reports  (7/29/20)
CloudMD reported it entered into a definitive agreement to acquire South Surrey Medical Clinic in Metro Vancouver in a combination stock and cash deal valued at CA$700,000. More >

Kodak Shares Triple in a Flash on $765 Million Loan from DFC for New Pharmaceutical Unit
Source: Streetwise Reports  (7/28/20)
Eastman Kodak shares traded more than 200% higher after the company reported it is forming a new business unit to produce essential pharmaceutical components funded by the U.S. International Development Finance Corporation. More >

TCR2 Therapeutics Reports Positive Results in Mesothelin-Expressing Solid Tumor Study
Source: Streetwise Reports  (7/27/20)
Shares of TCR2 Therapeutics traded 30% higher after the firm released encouraging results from the Phase 1 portion of its clinical study of TC-210 in treating advanced mesothelin-expressing solid tumors.

More >

Milestone Shares More than Double After Presenting Updated Clinical Plan for Heart Condition
Source: Streetwise Reports  (7/23/20)
Shares of Milestone Pharmaceuticals traded 150% higher after the company reported regulatory guidance and updated its clinical development plan for etripamil nasal spray designed for self-administered use in PSVT treatment. More >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'
Source: Streetwise Reports  (7/22/20)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. More >

HCA Healthcare Shares Move Up on Q2 Earnings and Resumption of Non-Emergency Procedures
Source: Streetwise Reports  (7/22/20)
Shares of HCA Healthcare traded more than 10% higher after the company reported Q2/20 financial results and advised it has seen a gradual rise in patient volumes in May and June for elective and non-emergency procedures. More >

Owens & Minor Shares Trade 75% Higher on Preliminary Q2 Earnings and Raised FY Guidance
Source: Streetwise Reports  (7/21/20)
Shares of Owens & Minor reached a new 52-week high after the company reported preliminary Q2/20 results and raised FY/20 earnings guidance. More >

AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports  (7/20/20)
Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform. More >

Innovative Telehealth Company to Acquire Firm with Mental Health Platform
Source: Streetwise Reports  (7/18/20)
With this transaction, CloudMD Software & Services will become Canada's first telemedicine company with both primary care and mental health care components. More >

Dynavax Shares Rise 20% on Partnership with Mount Sinai to Develop Universal Flu Vaccine
Source: Streetwise Reports  (7/17/20)
Shares of Dynavax Technologies reached a new 52-week high after the company reported that it is collaborating with Mount Sinai to develop a universal influenza vaccine candidate with CpG 1018 adjuvant. More >

Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes.
Source: Peter Epstein for Streetwise Reports  (7/17/20)
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD. More >

Threat Detection Company's AI Division Partners with Healthcare Firm to Increase Cancer Testing Access
Source: Streetwise Reports  (7/16/20)
Patriot One Technologies reported its Xtract AI division is working with Canexia Health to increase access to cancer testing as part of the Digital Technology Supercluster COVID-19 Program project. More >

AC Immune Shares Rise 19% as Firm Advances Alzheimer's Vaccine in Phase 1b/2a Trial
Source: Streetwise Reports  (7/16/20)
AC Immune SA shares set a new 52-week high after the Swiss biotech firm reported that interim data from its Phase 1b/2a phospho-Tau Alzheimer's Vaccine study reconfirms promising safety and Tau-specific immunogenicity observed in the prior clinical trial. More >